Yngve Nordby
Overview
Explore the profile of Yngve Nordby including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
373
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Richardsen E, Andersen S, Melbo-Jorgensen C, Rakaee M, Ness N, Al-Saad S, et al.
Sci Rep
. 2019 Jan;
9(1):386.
PMID: 30674952
A large number of miRNAs influence key cellular processes involved in prostate tumorigenesis. Previous studies have demonstrated high expression of miRNAs in human prostate cancer (PC) tissues and cell lines....
2.
Grindstad T, Richardsen E, Andersen S, Skjefstad K, Rakaee Khanehkenari M, Donnem T, et al.
Sci Rep
. 2018 Jul;
8(1):11358.
PMID: 30054508
The role of steroid hormones in carcinogenesis of the prostate is to some extent unraveled thorough the effect of androgen deprivation therapy on prostate cancer (PCa) progression. Other members of...
3.
Nordby Y, Richardsen E, Ness N, Donnem T, Patel H, Busund L, et al.
Sci Rep
. 2017 Nov;
7(1):16308.
PMID: 29176717
Due to insufficient prognostic tools, failure to predict aggressive prostate cancer (PC) has left patient selection for radical treatment an unsolved challenge. This has resulted in overtreatment with radical therapy....
4.
Richardsen E, Andersen S, Al-Saad S, Rakaee M, Nordby Y, Pedersen M, et al.
PLoS One
. 2017 Nov;
12(11):e0186852.
PMID: 29141018
The tumor proliferation index marker Ki-67 is strongly associated with tumor cell proliferation, growth and progression, and is widely used in routine clinicopathological investigation. Prostate cancer is a complex multifaceted...
5.
Ness N, Andersen S, Rakaee Khanehkenari M, Nordbakken C, Valkov A, Paulsen E, et al.
Oncotarget
. 2017 May;
8(16):26789-26801.
PMID: 28460462
Programmed cell death protein 1 (PD-1) and its ligand Programmed death ligand 1 (PD-L1) have gained massive attention in cancer research due to recent availability and their targeted antitumor effects....
6.
Nordby Y, Richardsen E, Rakaee M, Ness N, Donnem T, Patel H, et al.
Sci Rep
. 2017 Feb;
7:43378.
PMID: 28233816
Due to a lack of sufficient diagnostic tools to predict aggressive disease, there is a significant overtreatment of patients with prostate cancer. Platelet derived growth factors (PDGFs) and their receptors...
7.
Andersen S, Richardsen E, Moi L, Donnem T, Nordby Y, Ness N, et al.
Sci Rep
. 2016 Nov;
6:36573.
PMID: 27824162
There is a need for better prognostication in prostate cancer (PC). "The micromanager of hypoxia", microRNA-210 (miR-210) is directly linked to hypoxia, is overexpressed in PC and has been implied...
8.
Grindstad T, Skjefstad K, Andersen S, Ness N, Nordby Y, Al-Saad S, et al.
Sci Rep
. 2016 Sep;
6:33114.
PMID: 27610593
Androgens are considered important in normal prostate physiology and prostate cancer (PCa) pathogenesis. However, androgen-targeted treatment preventing PCa recurrence is still lacking. This indicates additional mediators contributing to cancer development....
9.
The prognostic significance of CXCL16 and its receptor C-X-C chemokine receptor 6 in prostate cancer
Richardsen E, Ness N, Melbo-Jorgensen C, Johannesen C, Grindstad T, Nordbakken C, et al.
Am J Pathol
. 2015 Aug;
185(10):2722-30.
PMID: 26272362
The chemokine CXCL16 and its receptor, C-X-C chemokine receptor (CXCR6), affect tumor progression through different pathways, including leukocyte recruitment and function, cellular senescence, tumor cell proliferation, survival, invasion, and metastasis....
10.
Nordby Y, Andersen S, Richardsen E, Ness N, Al-Saad S, Melbo-Jorgensen C, et al.
Prostate
. 2015 Aug;
75(15):1682-93.
PMID: 26268996
Background: There is probably significant overtreatment of patients with prostate cancer due to a lack of sufficient diagnostic tools to predict aggressive disease. Vascular endothelial growth factors (VEGFs) and their...